Company intelligence / Profile preview

Beijing Aibang Weiye

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Beijing Aibang Weiye Pharmaceutical Technology is a specialized Contract Research Organization (CRO) based in China that provides a full suite of clinical development and regulatory services. Established in 2011, the company focuses on clinical trial management for Phase I through IV studies, including clinical monitoring, data management, and biostatistics. It has developed a strong reputation for assisting pharmaceutical companies with the consistency evaluation of generic drugs to meet National Medical Products Administration (NMPA) standards. Additionally, Aibang Weiye offers Site Management Organization (SMO) support and expert consultation for drug registration and regulatory filings within the Chinese market.

Modalities: Small molecule
Industry: Contract Research Organization

Beyond the preview

Go deeper on Beijing Aibang Weiye.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Aibang Weiye.